Latest news
- Jun 21, 2018 – Alligator Bioscience’s ATOR-1017 strongly activates both T cells and NK cells, important for the effective eradication of tumor cells
- May 29, 2018 – Alligator Bioscience Capital Markets Day today on May, 29
- May 16, 2018 – Invitation to Alligator Bioscience Capital Markets Day in Stockholm on May 29, 2018
Latest News
- 21 Jun 2018 – Alligator Bioscience’s ATOR-1017 strongly activates both T cells and NK cells, important for the effective eradication of tumor cells
- 29 May 2018 – Alligator Bioscience Capital Markets Day today on May, 29
- 16 May 2018 – Invitation to Alligator Bioscience Capital Markets Day in Stockholm on May 29, 2018
- 8 May 2018 – New Preclinical Data for Novel Immunotherapy Bispecific Candidate ALG.APV-527 presented by Alligator Bioscience and Aptevo Therapeutics
- 3 May 2018 – Alligator Bioscience: ATOR-1017 pre-clinical data support a best-in-class 4-1BB antibody profile
Calendar
- Jul 12, 2018 - Interim Report Apr-Jun 2018
- Feb 14, 2019 - Full Year Report 2018
